The AI giant continues to innovate, too, promising to update its chips on an annual basis. Nvidia has proven it can follow ...

Just about every big tech company in the world is in a race to build more computing capacity than anyone else in order to ...

Revolution Medicines has zeroed in on Iambic Therapeutics’ AI drug discovery platform, striking a multi-year technology and research collaboration that gives Iambic the chance to earn up to $25 mil | ...

Custom-built model will be trained using Revolution Medicines’ proprietary data to discover novel drug candidatesIambic to ...

Similar to last year, stocks such as Palantir, Nvidia, and Microsoft remain among the hottest names driving the artificial ...

Investor attention is once again drifting toward Aptos and Ethereum as charts present more favorable price patterns. Yet Ozak ...

Revolution Medicine’s proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand prediction from Iambic.

Google unveiled its AI-driven Weather Lab last month, giving forecasters another research tool to predict the intensity and ...

A new AI model mimics human thinking with striking accuracy, even in unfamiliar scenarios. Researchers at Helmholtz Munich ...

OpenAI CEO Sam Altman has made several predictions about where we're headed on AGI, superintelligence, and agentic AI — and ...

Hype around a Microsoft AI agent's ability to diagnose difficult cases misses the mark and overlooks real innovation, experts ...

By learning electron-level information, Korean researchers have created an artificial intelligence (AI) tool that can ...